BIOTRON LIMITED - Announcements

Market Cap $18.04M Add to my watchlist

Healthcare Biotechnology

Biotron Limited is an Australia-based biotechnology company. The Company is primarily... Biotron Limited is an Australia-based biotechnology company. The Company is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Company’s clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BIT	Results of Meeting		28/11/12	29.33KB	Share
BIT	Chairman's Address and Presentation to the AGM		28/11/12	422.41KB	Share
BIT	Commencement of Three-Month Toxicology Studies For BIT225	PRICE SENSITIVE	27/11/12	48.93KB	Share
BIT	Presentation of BIT225 HCV 48-week data at AASLD Conference	PRICE SENSITIVE	16/11/12	961.96KB	Share
BIT	Key Phase 2 HIV/HCV Trial Commenced	PRICE SENSITIVE	09/11/12	50.25KB	Share
BIT	Presentation to Investors		26/10/12	317.86KB	Share
BIT	Annual Report and Notice of AGM		25/10/12	1.12MB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/12	37.67KB	Share
BIT	Biotron to Present Positive 48 Week Data from HCV Trial	PRICE SENSITIVE	16/10/12	55.68KB	Share
BIT	Shareholder Update		11/10/12	559.71KB	Share
BIT	Change of Director's Interest Notice		12/09/12	38.94KB	Share
BIT	Change of Director's Interest Notice		10/09/12	39.31KB	Share
BIT	App 4E / Full Year Statutory Accounts	PRICE SENSITIVE	31/08/12	467.75KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/12	78.17KB	Share
BIT	Change of Director's Interest Notice		15/06/12	110.63KB	Share
BIT	Shareholder Update		04/05/12	239.29KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	20/04/12	49.11KB	Share
BIT	Appendix 3B		03/04/12	108.21KB	Share
BIT	Appointment of Directors		07/03/12	32.45KB	Share
BIT	Option Expiry Notice		29/02/12	71.92KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/12	144.7KB	Share
BIT	CEO Presentation at International Investor Conference		15/02/12	383.66KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	24/01/12	49.12KB	Share
BIT	ASX price query and response	PRICE SENSITIVE	16/01/12	72.21KB	Share
BIT	Presentation to Investors		12/01/12	374.97KB	Share
BIT	Change of Director's Interest Notice		09/01/12	103.13KB	Share
BIT	Exercise of Options Raises $8.0 Million	PRICE SENSITIVE	06/01/12	93.74KB	Share
BIT	Change of Director's Interest Notice		09/12/11	48.95KB	Share
BIT	Letter to Security Holders		09/12/11	219.19KB	Share
BIT	Change of Director's Interest Notice		09/12/11	48.92KB	Share
BIT	Change of Director's Interest Notice		08/12/11	48.98KB	Share
BIT	POSITIVE 3 MONTH DATA FOR BIT225 - 87% VIRUS FREE	PRICE SENSITIVE	07/12/11	71.16KB	Share
BIT	Response to ASX query		02/12/11	57.62KB	Share
BIT	Option Expiry Notice		30/11/11	57.02KB	Share
BIT	Change of Director's Interest Notice		30/11/11	49.5KB	Share
BIT	Appendix 3B		25/11/11	60.77KB	Share
BIT	Results of Meeting		22/11/11	24.16KB	Share
BIT	Presentation to Annual General Meeting		22/11/11	245.17KB	Share
BIT	Final Director's Interest Notice		21/11/11	27.23KB	Share
BIT	Dr. Michael Hirshorn		18/11/11	20.67KB	Share
BIT	Biotron Presentation at International Hepatitis Conference		18/11/11	38.72KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/11	49.09KB	Share
BIT	Annual Report and Notice of Annual General Meeting		24/10/11	645.8KB	Share
BIT	Letter to Shareholders		24/10/11	220KB	Share
BIT	Appendix 3B		24/10/11	300.67KB	Share
BIT	Presentation to Investors		19/10/11	167.77KB	Share
BIT	Boardroom Radio Broadcast		11/10/11	20.58KB	Share
BIT	HEPATITIS C PHASE 2A TRIAL POSITIVE RESULTS	PRICE SENSITIVE	10/10/11	163.28KB	Share
BIT	Trading Halt	PRICE SENSITIVE	07/10/11	52.95KB	Share
BIT	Landmark HIV Trial Underway	PRICE SENSITIVE	29/09/11	23.57KB	Share
BIT	Year End Accounts and Preliminary Final Report	PRICE SENSITIVE	30/08/11	448.31KB	Share
BIT	Letter to Shareholders		29/07/11	215.66KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/11	49.14KB	Share
BIT	Final Patient Dosed in Landmark Hepatitis C Trial		07/07/11	78.78KB	Share
BIT	CEO Presentation at BIO2011 in Washington DC		01/07/11	1.78MB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	19/04/11	49.12KB	Share
BIT	New Issue - Appendix 3B	PRICE SENSITIVE	04/04/11	116.25KB	Share
BIT	Presentation to Investors		31/03/11	1.42MB	Share
BIT	Trading Halt	PRICE SENSITIVE	31/03/11	52.38KB	Share
BIT	Biotron Share Purchase Plan		28/03/11	148.45KB	Share
BIT	Letter to Shareholders		16/03/11	309.15KB	Share
BIT	Stage 1 of Landmark HCV Drug Trial Completed	PRICE SENSITIVE	10/03/11	52.67KB	Share
AAX +ABQ ADY CT1 AIV AKF APE DXC ARA AUK AZT AZX BBG BBL BIT BPO HPP BUL CCD CDD CLH CNH COI COK CPB CTO AQX DML DON DTG DVN EBG EMM ERA EXE FKP FLT GBP RNE GLL GPM AMN GWA HBS HIG QXR ICN IDL JIN KME LAU LDW MCC MNZ MST NHC OAK OCE OVT PAX PGL SKY PNA PNN PNR QRN RCT RFG RFX RPF RPX RUL SAP SDM SMR SUM SWL SXR TPA TPI TXN OAR VBA VTG WBB WEC WHC WIG WTF WTP	Change of Share Registry Address		07/03/11	65.93KB	Share
BIT	Appendix 3B		02/03/11	72.08KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/11	185.6KB	Share
BIT	Biotron Share Purchase Plan	PRICE SENSITIVE	24/02/11	105.07KB	Share
BIT	Response to ASX Query re Appendix 4C	PRICE SENSITIVE	07/02/11	43.53KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/11	49.08KB	Share
BIT	US BIOTECH SHOWCASE PRESENTATION		12/01/11	1.82MB	Share
BIT	Grant of Options and Appendices 3B and 3Y		24/12/10	67.65KB	Share
BIT	Security Trading Policy		23/12/10	65.06KB	Share
BIT	Appendix 3B		02/12/10	68.17KB	Share
BIT	Results of Meeting		26/11/10	23.3KB	Share
BIT	Presentation to Annual General Meeting		26/11/10	769.01KB	Share
BIT	International Study Supports Biotron's HIV Drug Approach	PRICE SENSITIVE	25/11/10	50.56KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/10	49.21KB	Share
BIT	Annual Report and Notice of Annual General Meeting		27/10/10	4.44MB	Share
BIT	Presentation to Investors		20/10/10	178.38KB	Share
BIT	Letter to Shareholders		14/10/10	221.89KB	Share
BIT	Phase II HCV Trial Commenced	PRICE SENSITIVE	01/10/10	67.7KB	Share
BIT	Preliminary Final Report	PRICE SENSITIVE	31/08/10	966.84KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/10	49.29KB	Share
BIT	Presentation at International AIDS Conference	PRICE SENSITIVE	23/07/10	35.02KB	Share
BIT	Letter to Shareholders		30/06/10	269.58KB	Share
BIT	Appendix 3B		28/05/10	68.27KB	Share
BIT	Change of Director's Interest Notice		19/05/10	28.09KB	Share
BIT	Appointment of a Director		30/04/10	26.41KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	22/04/10	49.25KB	Share
BIT	Exercise of Options and Appendix 3B		08/04/10	62.11KB	Share
BIT	Director Resignation		01/04/10	27.16KB	Share
BIT	Shareholder Update and 'Piggy Back' Options Opportunity		19/03/10	359.73KB	Share
BIT	Biotron HCV Drug - International Partner to Progress Trial	PRICE SENSITIVE	18/03/10	68.17KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/10	95.53KB	Share
BIT	Allotment and Top 20 securityholders - Options		05/02/10	38.09KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/10	49.19KB	Share
BIT	Change of Director's Interest Notices		22/01/10	34.56KB	Share
BIT	Entitlement Issue 23% Oversubscribed		15/01/10	21.07KB	Share
BIT	Breakthrough HIV Treatment Progresses	PRICE SENSITIVE	17/12/09	24.82KB	Share
BIT	HCV Drug Success Presented to International Conference	PRICE SENSITIVE	14/12/09	70.8KB	Share
BIT	Option Entitlement Issue and Appendix 3B	PRICE SENSITIVE	10/12/09	473.84KB	Share

BITResults of Meeting
28/11/12		29.33KB	Share
BITChairman's Address and Presentation to the AGM
28/11/12		422.41KB	Share
BITCommencement of Three-Month Toxicology Studies For BIT225
27/11/12	PRICE SENSITIVE	48.93KB	Share
BITPresentation of BIT225 HCV 48-week data at AASLD Conference
16/11/12	PRICE SENSITIVE	961.96KB	Share
BITKey Phase 2 HIV/HCV Trial Commenced
09/11/12	PRICE SENSITIVE	50.25KB	Share
BITPresentation to Investors
26/10/12		317.86KB	Share
BITAnnual Report and Notice of AGM
25/10/12		1.12MB	Share
BITAppendix 4C - quarterly
22/10/12	PRICE SENSITIVE	37.67KB	Share
BITBiotron to Present Positive 48 Week Data from HCV Trial
16/10/12	PRICE SENSITIVE	55.68KB	Share
BITShareholder Update
11/10/12		559.71KB	Share
BITChange of Director's Interest Notice
12/09/12		38.94KB	Share
BITChange of Director's Interest Notice
10/09/12		39.31KB	Share
BITApp 4E / Full Year Statutory Accounts
31/08/12	PRICE SENSITIVE	467.75KB	Share
BITAppendix 4C - quarterly
27/07/12	PRICE SENSITIVE	78.17KB	Share
BITChange of Director's Interest Notice
15/06/12		110.63KB	Share
BITShareholder Update
04/05/12		239.29KB	Share
BITAppendix 4C - quarterly
20/04/12	PRICE SENSITIVE	49.11KB	Share
BITAppendix 3B
03/04/12		108.21KB	Share
BITAppointment of Directors
07/03/12		32.45KB	Share
BITOption Expiry Notice
29/02/12		71.92KB	Share
BITHalf Yearly Report and Accounts
28/02/12	PRICE SENSITIVE	144.7KB	Share
BITCEO Presentation at International Investor Conference
15/02/12		383.66KB	Share
BITAppendix 4C - quarterly
24/01/12	PRICE SENSITIVE	49.12KB	Share
BITASX price query and response
16/01/12	PRICE SENSITIVE	72.21KB	Share
BITPresentation to Investors
12/01/12		374.97KB	Share
BITChange of Director's Interest Notice
09/01/12		103.13KB	Share
BITExercise of Options Raises $8.0 Million
06/01/12	PRICE SENSITIVE	93.74KB	Share
BITChange of Director's Interest Notice
09/12/11		48.95KB	Share
BITLetter to Security Holders
09/12/11		219.19KB	Share
BITChange of Director's Interest Notice
09/12/11		48.92KB	Share
BITChange of Director's Interest Notice
08/12/11		48.98KB	Share
BITPOSITIVE 3 MONTH DATA FOR BIT225 - 87% VIRUS FREE
07/12/11	PRICE SENSITIVE	71.16KB	Share
BITResponse to ASX query
02/12/11		57.62KB	Share
BITOption Expiry Notice
30/11/11		57.02KB	Share
BITChange of Director's Interest Notice
30/11/11		49.5KB	Share
BITAppendix 3B
25/11/11		60.77KB	Share
BITResults of Meeting
22/11/11		24.16KB	Share
BITPresentation to Annual General Meeting
22/11/11		245.17KB	Share
BITFinal Director's Interest Notice
21/11/11		27.23KB	Share
BITDr. Michael Hirshorn
18/11/11		20.67KB	Share
BITBiotron Presentation at International Hepatitis Conference
18/11/11		38.72KB	Share
BITAppendix 4C - quarterly
27/10/11	PRICE SENSITIVE	49.09KB	Share
BITAnnual Report and Notice of Annual General Meeting
24/10/11		645.8KB	Share
BITLetter to Shareholders
24/10/11		220KB	Share
BITAppendix 3B
24/10/11		300.67KB	Share
BITPresentation to Investors
19/10/11		167.77KB	Share
BITBoardroom Radio Broadcast
11/10/11		20.58KB	Share
BITHEPATITIS C PHASE 2A TRIAL POSITIVE RESULTS
10/10/11	PRICE SENSITIVE	163.28KB	Share
BITTrading Halt
07/10/11	PRICE SENSITIVE	52.95KB	Share
BITLandmark HIV Trial Underway
29/09/11	PRICE SENSITIVE	23.57KB	Share
BITYear End Accounts and Preliminary Final Report
30/08/11	PRICE SENSITIVE	448.31KB	Share
BITLetter to Shareholders
29/07/11		215.66KB	Share
BITAppendix 4C - quarterly
27/07/11	PRICE SENSITIVE	49.14KB	Share
BITFinal Patient Dosed in Landmark Hepatitis C Trial
07/07/11		78.78KB	Share
BITCEO Presentation at BIO2011 in Washington DC
01/07/11		1.78MB	Share
BITAppendix 4C - quarterly
19/04/11	PRICE SENSITIVE	49.12KB	Share
BITNew Issue - Appendix 3B
04/04/11	PRICE SENSITIVE	116.25KB	Share
BITPresentation to Investors
31/03/11		1.42MB	Share
BITTrading Halt
31/03/11	PRICE SENSITIVE	52.38KB	Share
BITBiotron Share Purchase Plan
28/03/11		148.45KB	Share
BITLetter to Shareholders
16/03/11		309.15KB	Share
BITStage 1 of Landmark HCV Drug Trial Completed
10/03/11	PRICE SENSITIVE	52.67KB	Share
AAX +ABQ ADY CT1 AIV AKF APE DXC ARA AUK AZT AZX BBG BBL BIT BPO HPP BUL CCD CDD CLH CNH COI COK CPB CTO AQX DML DON DTG DVN EBG EMM ERA EXE FKP FLT GBP RNE GLL GPM AMN GWA HBS HIG QXR ICN IDL JIN KME LAU LDW MCC MNZ MST NHC OAK OCE OVT PAX PGL SKY PNA PNN PNR QRN RCT RFG RFX RPF RPX RUL SAP SDM SMR SUM SWL SXR TPA TPI TXN OAR VBA VTG WBB WEC WHC WIG WTF WTPChange of Share Registry Address
07/03/11		65.93KB	Share
BITAppendix 3B
02/03/11		72.08KB	Share
BITHalf Yearly Report and Accounts
28/02/11	PRICE SENSITIVE	185.6KB	Share
BITBiotron Share Purchase Plan
24/02/11	PRICE SENSITIVE	105.07KB	Share
BITResponse to ASX Query re Appendix 4C
07/02/11	PRICE SENSITIVE	43.53KB	Share
BITAppendix 4C - quarterly
27/01/11	PRICE SENSITIVE	49.08KB	Share
BITUS BIOTECH SHOWCASE PRESENTATION
12/01/11		1.82MB	Share
BITGrant of Options and Appendices 3B and 3Y
24/12/10		67.65KB	Share
BITSecurity Trading Policy
23/12/10		65.06KB	Share
BITAppendix 3B
02/12/10		68.17KB	Share
BITResults of Meeting
26/11/10		23.3KB	Share
BITPresentation to Annual General Meeting
26/11/10		769.01KB	Share
BITInternational Study Supports Biotron's HIV Drug Approach
25/11/10	PRICE SENSITIVE	50.56KB	Share
BITAppendix 4C - quarterly
27/10/10	PRICE SENSITIVE	49.21KB	Share
BITAnnual Report and Notice of Annual General Meeting
27/10/10		4.44MB	Share
BITPresentation to Investors
20/10/10		178.38KB	Share
BITLetter to Shareholders
14/10/10		221.89KB	Share
BITPhase II HCV Trial Commenced
01/10/10	PRICE SENSITIVE	67.7KB	Share
BITPreliminary Final Report
31/08/10	PRICE SENSITIVE	966.84KB	Share
BITAppendix 4C - quarterly
30/07/10	PRICE SENSITIVE	49.29KB	Share
BITPresentation at International AIDS Conference
23/07/10	PRICE SENSITIVE	35.02KB	Share
BITLetter to Shareholders
30/06/10		269.58KB	Share
BITAppendix 3B
28/05/10		68.27KB	Share
BITChange of Director's Interest Notice
19/05/10		28.09KB	Share
BITAppointment of a Director
30/04/10		26.41KB	Share
BITAppendix 4C - quarterly
22/04/10	PRICE SENSITIVE	49.25KB	Share
BITExercise of Options and Appendix 3B
08/04/10		62.11KB	Share
BITDirector Resignation
01/04/10		27.16KB	Share
BITShareholder Update and 'Piggy Back' Options Opportunity
19/03/10		359.73KB	Share
BITBiotron HCV Drug - International Partner to Progress Trial
18/03/10	PRICE SENSITIVE	68.17KB	Share
BITHalf Yearly Report and Accounts
26/02/10	PRICE SENSITIVE	95.53KB	Share
BITAllotment and Top 20 securityholders - Options
05/02/10		38.09KB	Share
BITAppendix 4C - quarterly
27/01/10	PRICE SENSITIVE	49.19KB	Share
BITChange of Director's Interest Notices
22/01/10		34.56KB	Share
BITEntitlement Issue 23% Oversubscribed
15/01/10		21.07KB	Share
BITBreakthrough HIV Treatment Progresses
17/12/09	PRICE SENSITIVE	24.82KB	Share
BITHCV Drug Success Presented to International Conference
14/12/09	PRICE SENSITIVE	70.8KB	Share
BITOption Entitlement Issue and Appendix 3B
10/12/09	PRICE SENSITIVE	473.84KB	Share

REFRESH

First 2 3 4 5

(20min delay)
Last 2.0¢		Change -0.001(4.76%)		Mkt cap ! $18.04M

Open	High	Low	Value	Volume
2.1¢	2.1¢	2.0¢	$12.00K	600.2K

Buyers (Bids)

No.	Vol.	Price($)
5	972631	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.1¢	199783	1

View Market Depth

No.	Vol.	Price($)
5	972631	0.019
10	2364942	0.018
6	738000	0.017
11	1456225	0.016
4	635000	0.015

Price($)	Vol.	No.
0.021	199783	1
0.022	41868	2
0.023	506413	1
0.024	222185	3
0.025	600000	3

Last trade - 14.33pm 01/11/2024 (20 minute delay)


Last 2.0¢		Change -0.001 ( 4.76 %)
Open	High	Low	Volume
2.0¢	2.0¢	2.0¢	199442
Last updated 14.33pm 01/11/2024 ?

BIT (ASX) Chart

BIOTRON LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available